Suppression of caspase-11 expression by histone deacetylase inhibitors

Area of Science:

• Molecular Biology
• Immunology
• Biochemistry

Background:

• Histone deacetylase (HDAC) inhibitors are known to suppress inflammatory gene expression.
• Caspase-11 is an inducible caspase that plays a critical role in regulating both inflammation and apoptosis.
• Understanding the regulation of caspase-11 is crucial for developing novel therapeutic strategies for inflammatory diseases.

Purpose of the Study:

• To investigate the effect of HDAC inhibitors on the expression of caspase-11.
• To elucidate the signaling pathways modulated by HDAC inhibitors in the context of caspase-11 induction.

Main Methods:

• Treatment of mouse embryonic fibroblasts with lipopolysaccharides (LPS) to induce caspase-11.
• Administration of two structurally unrelated HDAC inhibitors: sodium butyrate and trichostatin A.
• Analysis of upstream signaling events including p38 MAPK, JNK, IκB degradation, and NF-κB activation.

Main Results:

• Sodium butyrate and trichostatin A effectively suppressed the induction of caspase-11 in LPS-stimulated mouse embryonic fibroblasts.
• Sodium butyrate inhibited key upstream signaling events, including p38 MAPK and JNK activation, IκB degradation, and NF-κB activation.
• These findings indicate that HDAC inhibitors interfere with cytosolic signaling pathways leading to caspase-11 induction.

Conclusions:

• HDAC inhibitors suppress caspase-11 induction, suggesting a role in modulating inflammatory and apoptotic responses.
• The suppression of caspase-11 induction by HDAC inhibitors is mediated through the inhibition of cytosolic signaling events.
• Targeting HDACs may represent a potential therapeutic approach for inflammatory conditions involving caspase-11 activation.